Clue gets FDA clearance for digital birth control

BioWink GmbH Secures $7million In Funding From Investors

Clue, best known for its period tracking app, announced that it received clearance from the Food and Drug Administration for a digital birth control function, which it says can help users prevent pregnancy based only on the start date of a user’s period. It calculates the window where someone could get pregnant based on statistical modeling.

“It personalizes over time. So as the individual puts in their cycle day one then we’re able to personalize the window of their high risk days vs their low risk days,” Clue’s chief medical officer Lynae Brayboy told TechCrunch.

The company plans to launch its digital birth control some time this year.

Clue says that its digital birth control is 92 percent effective at preventing unwanted pregnancy…

Continue reading…

via The Verge – All Posts

Check out the Finding Your Identity Podcast!